Prof. Züleyha Çalikuşu is a medical oncologist with clinical and academic training from Başkent University Faculty of Medicine, where she completed her medical oncology education in 2007. Since 2010 she has been practicing with the Acıbadem Health Group, providing comprehensive cancer care and contributing to multidisciplinary treatment teams. Dr. Çalikuşu is an active member of the Medical Oncology Society and the Anatolian Medical Oncology Association, engaging with professional peers to stay current in oncology practice and advances. She is committed to evidence-based care, patient-centered communication, and improving outcomes for individuals facing cancer.
Education
- 2007 Başkent University Faculty of Medicine Medical Oncology
- 2003 Çukurova University Faculty of Medicine Internal Medicine
- 1997 Cukurova University Faculty of Medicine
Experience
- 2010 Acibadem Health Group
- 2007 – 2009 Erzurum Numune Training and Research Hospital Medical Oncology
- 2003 – 2007 Başkent University Faculty of Medicine / Medical Oncology
- 1991 – 2003 Çukurova University Faculty of Medicine / Internal Medicine Residency
Memberships
- Medical Oncology Society
- Anatolian Medical Oncology Association
Publications
- Intramuscular metastases detected by PET/CT in a patient with renal cell tumor
Acıbadem University Journal of Health Sciences , 49-50 pp., 2010 Volkan Beylergil, Özlem Er, Züleyha Çalıkuşu, Erkan Vardareli, - A case of bladder carcinoma metastasizing to the penis
179-180 pp., 2010 Züleyha Çalıkuşu, Şerife Ulusan, Hakan Sakallı, Bahattin Yılmaz, Hüseyin Mertsoylu, Zafer Akçalı, Özgür Özyılkan, - Prognostic significance of the C-erbB-2 expression in Turkish non-small cell lung cancer patients.
Asian Pac J Cancer Prev. 2009 Jul-Sep;10(3):479-82. Calikusu Z, Yildirim Y, Akcali Z, Sakalli H, Bal N, Ozyilkan O. - Manegement of elderly patients with advanced non-small cell lung cancer in Turkey
Yildirim Y., Ozyilkan O., Calikusu Z., Akcali Z., Akcay Y., Demirhan B. Asian Pac J Cancer Prev. 2009 Oct-Dec;10(4):699-700 - The effect of HER2 expression on cisplatin-based chemotherapy in advanced non-small cell lung cancer patients.
J Exp Clin Cancer Res. 2009 Jul 3;28(1) :97. Z. Calikusu, Yildirim Y, Akcali Z, Sakalli H, Bal N, Unal I, Ozyilkan O. - Micronucleus analysis in patients with colorectal adenocarcinoma and colorectal polyps.
World J Gastroenterol 2008 Nov 28; 14; 14(44): 6835-9. A. Karaman, D. N. Binici, M. E. Kabalar, Z. Çalikuşu . - Gemcitabine and Cisplatin Treatment of Advanced -Stage Non-Small Cell Lung Cancer in Patients Given Cisplatin on Day 8.
Tumori 2008 Jul-Aug;94(4):474-80. Z. Akcali, Z. Calikusu, H. Sakalli, O. Ozyilkan. - Prothrombotic heritable risk factors for cerebral ischemic infarction, acute myocardial infarction and venous thrombosis in young adult Turkish patients
Annals of Medical Sciences , 31-36 pp., 2005 Z. Karakus, E. Gurkan, F. Baslamışli, K. Tanrıverdi
